A new study demonstrates that combining fMRI brain connectivity, cognitive reward testing, and clinical markers to guide antidepressant selection increases patient response rates by nearly 67%.
A new study demonstrates that combining fMRI brain connectivity, cognitive reward testing, and clinical markers to guide antidepressant selection increases patient response rates by nearly 67%.
Share this Article
Recommended